drugdeliverybusiness3d
Medtronic kicks off Blue Balloon Challenge for National Diabetes Awareness Month
Que Dallara, EVP and president of Medtronic Diabetes, wrote on LinkedIn: ...
drugdeliverybusiness3d
Insulet announces diabetes awareness initiatives for November
Insulet (Nasdaq:PODD) today announced its plans to recognize National Diabetes Awareness Month and World Diabetes Day.
drugdeliverybusiness5d
FDA approves Abbott CGMs for use during medical imaging
Abbott announced today that the FDA said users can wear the FreeStyle Libre 2 and 3 CGMs during common imaging procedures.
drugdeliverybusiness5d
Beta Bionics launches iLet bionic pancreas with Abbott FreeStyle Libre 3 Plus
Beta Bionics announced today that it launched the integration of the iLet bionic pancreas with the Abbott (NYSE:ABT) ...
drugdeliverybusiness6d
Food & Drug Administration (FDA)
Abbott (NYSE:ABT) announced today that the FDA said users can wear the FreeStyle Libre 2 and 3 CGMs during common imaging procedures. The FDA cleared the removal of the imaging contradiction for the ...
drugdeliverybusiness6d
Insulet fully launches Omnipod 5 app for iPhone in U.S.
Insulet (Nasdaq:PODD) today announced the full market release of the Omnipod 5 automated insulin delivery app for iPhone in the U.S.
drugdeliverybusiness6d
Insulcloud wins FDA nod to bring smart insulin pen cap tech to U.S.
Insulcloud today announced its strategic expansion into the U.S. following FDA clearance for its Insulclock CAP smart device.
drugdeliverybusiness7d
Dexcom submits 15-day CGM to FDA, beats Street in Q3
Dexcom announced today that, following the conclusion of the third quarter, it submitted its 15-day G7 CGM to the FDA.